Mylan Laboratories Inc. Interested in Merck KGaA Drug Unit
LONDON/FRANKFURT, Feb 28 (Reuters) - U.S.-based Mylan Laboratories Inc is interested in bidding for Merck KGaA's generics business, joining a growing of band of firms lining up offers, people familiar with the situation said on Wednesday.